SND1: A Protein Regulating Neural Processes and Potential Drug Target

Target Name: SND1

NCBI ID: G27044

SND1

SND1: A Protein Regulating Neural Processes and Potential Drug Target

SND1 (EBNA2 coactivator p100) is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the nervous system, and has been identified as a potential drug target for various psychiatric and neurological disorders.

The protein SND1 is composed of 194 amino acid residues and has a calculated molecular mass of 21.1 kDa. It is expressed in the brain and other nervous system tissues, and is also found in the heart, liver, and pancreas. It is a member of the EBNA2 coactivator subfamily, which is a group of proteins that play a role in the regulation of neural stem cell proliferation and differentiation.

SND1 has been shown to be involved in the regulation of a wide range of neural processes, including neuronal communication, synaptic plasticity, and neurotransmitter release. It has been shown to interact with a variety of different proteins, including the neurotransmitter acetylcholine, which is involved in memory and learning.

In addition to its role in neural processes, SND1 has also been shown to play a role in the regulation of inflammation and immune responses. It has been shown to interact with the immune protein PD-L1, and has been shown to contribute to the regulation of inflammation in the brain.

Given its involvement in a wide range of neural processes, SND1 has been identified as a potential drug target for a variety of psychiatric and neurological disorders. For example, SND1 has been shown to be involved in the regulation of anxiety and depression, and has been shown to interact with the neurotransmitter GABA, which is involved in these disorders.

In addition to its potential as a drug target, SND1 has also been shown to have potential as a biomarker for certain neurological disorders. For example, it has been shown to be involved in the regulation of the release of certain neurotransmitters, such as dopamine and GABA, and has been shown to be affected in conditions such as Alzheimer's disease and Parkinson's disease.

Overall, SND1 is a protein that has important roles in the regulation of neural processes and has been identified as a potential drug target and biomarker for a variety of psychiatric and neurological disorders. Further research is needed to fully understand the role of SND1 in these processes and to develop effective treatments for these disorders.

Protein Name: Staphylococcal Nuclease And Tudor Domain Containing 1

Functions: Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs (PubMed:28546213, PubMed:18453631). As part of its function in miRNA decay, regulates mRNAs involved in G1-to-S phase transition (PubMed:28546213). Functions as a bridging factor between STAT6 and the basal transcription factor (PubMed:12234934). Plays a role in PIM1 regulation of MYB activity (PubMed:9809063). Functions as a transcriptional coactivator for STAT5 (By similarity)

The "SND1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SND1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets